UALCAN analysis indicated a preferential up-regulation of ETAA1 and RPA1 in advanced liver cancer stages (Figures 3A, C) and in poorly differentiated tumor grades (Figures 3B, D), when compared to normal tissue controls. The gene discussed is RPA1; the disease is liver cancer.